S100A12 and Neonatal sepsis: Also, in humans, S100A12 has been proposed as a feasible biomarker of diagnostic and prognostic in sepsis, showing higher plasma concentration in patients with deadly septic shock in comparison to healthy individuals and survivor patients (32), and showed high sensitivity and specificity as serum biomarker of neonatal sepsis (33).